Science 37 Holdings

Science 37 Holdings, Inc. provides technology-based solutions that enables decentralized clinical trials. The company is headquartered in Durham, NC.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Genius Group Ltd

T2 Biosystems

Are you on the hunt for the best penny stocks to buy right now? If so, you're part of a growing community of traders.

Best Penny Stocks To Buy This Week? 3 Under $0.99 To Watch

RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended June 30, 2023.

Science 37 Reports Second Quarter 2023 Financial Results

RESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial results prior to the market open on Tuesday, August 8, 2023.

Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023

Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients

Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)

Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q1 2023 Earnings Call May 15, 2023 8:30 AM ET Company Participants Steve Halper - LifeSci Advisors David Coman - Chief Executive Officer Mike Zaranek - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Matthew Hewitt - Craig-Hallum Capital Group Frank Takkinen - Lake Street Capital Markets Operator Greetings, and welcome to the Science 37 First quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Science 37 Holdings, Inc. (SNCE) Q1 2023 Earnings Call Transcript

RESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended March 31, 2023.

Science 37 Reports First Quarter 2023 Financial Results

RESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial results prior to the market open on Monday, May 15, 2023.

Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023

New role supports the Company's objective to lead the industry with faster, more inclusive clinical research New role supports the Company's objective to lead the industry with faster, more inclusive clinical research

Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity

New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality New role supports the Company's objective to be the DCT industry's “undisputed leader” in quality

Science 37 Adds New Head of Quality, Irena Lambridis

RESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will host a business update conference call prior to the market open on Wednesday, April 12, 2023.

Science 37 to Host Business Update Call on April 12, 2023

Centers of Excellence to strengthen and scale the company's Metasite offering and accelerate its path to profitability Centers of Excellence to strengthen and scale the company's Metasite offering and accelerate its path to profitability

Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality

Science 37 (NASDAQ: SNCE ) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. According to a press release from Science 37, the awards were approved by its Board of Directors in November 2022.

Why Is Science 37 (SNCE) Stock Up 9% Today?

Science 37 Holdings Inc. (NASDAQ:SNCE ) Q4 2022 Earnings Conference Call March 6, 2023 8:30 AM ET Company Participants David Coman - Chief Executive Officer Mike Zaranek - Chief Financial Officer Steven Halper - LifeSci Advisors Conference Call Participants Frank Takkinen - Lake Street Capital Christine Rains - William Blair Charles Rhyee - TD Cowen Matt Hewitt - Craig Hallum Evan Stover - Baird Operator Greetings. Welcome to the Science 37 fourth quarter and full year 2022 earnings conference call.

Science 37 (SNCE) Q4 2022 Earnings Call Transcript

RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter and full year ended December 31, 2022.

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston.

Science 37 to Present at the Cowen 43rd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial results prior to the market open on Monday, March 6, 2023.

Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023

RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science 37 Holdings, Inc. 2022 Employment Inducement Incentive Award Plan (the “Plan”). The Plan was approved by Science 37's Board of Directors in November 2022. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Science 37's Compensation Committee and made as a material inducement to the non-executive employees' entry into employment with the Company.

Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, announced today that it has acquired the life sciences platform from Vault Health, a national leader in remote diagnostics and COVID testing, to further enhance clinical trial workflow orchestration and data interoperability capabilities of the Science 37 platform.

Science 37 Acquires Vault Health's Life Sciences Platform To Bolster its Metasite Capabilities

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming 5th Annual Evercore ISI HealthCONx Conference.

Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference

The partnership will enable Science 37 to directly access electronic medical record (EMR) data to find and match patients to clinical trials across its expanding community provider network, covering more than 35 million patient lives. The partnership will enable Science 37 to directly access electronic medical record (EMR) data to find and match patients to clinical trials across its expanding community provider network, covering more than 35 million patient lives.

Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers

As a certified partner, Linical will leverage Science 37's Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network As a certified partner, Linical will leverage Science 37's Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network

Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials

Science 37 is recognized for its unified platform to enable more patient-centric trials Science 37 is recognized for its unified platform to enable more patient-centric trials

Science 37 Named Best in Class for Telehealth Innovation at UCSF Health Hub Digital Health Awards 2022

Start Time: 08:30 January 1, 0000 9:07 AM ET Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q3 2022 Earnings Conference Call November 11, 2022, 08:30 AM ET Company Participants David Coman - CEO Mike Zaranek - CFO Steve Halper - Managing Director, LifeSci Advisors Conference Call Participants Steven Braun - Cowen Max Smock - William Blair Matthew Hewitt - Craig-Hallum Frank Takkinen - Lake Street Eric Coldwell - Baird David Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Science 37 Third Quarter 2022 Earnings Conference Call.

Science 37 Holdings, Inc. (SNCE) Q3 2022 Earnings Call Transcript

Science 37 Holdings, Inc. (SNCE) delivered earnings and revenue surprises of 5.88% and 21.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Science 37 Holdings Stock (SNCE)